Health news
Health news top Health news

   Login  |  Register    
Health News Make AMN Your Home PageDiscussion BoardsAdvanced Search ToolMedical RSS/XML News FeedHealth news
  You are here : Health.am > Health Centers > Drug Abuse -
Lawyers to meet next week on Merck’s Vioxx - NYT Lawyers to meet next week on Merck’s Vioxx - NYT

Lawyers to meet next week on Merck’s Vioxx - NYT

Drug AbuseNov 05, 2004

Drugs giant Merck & Co. which pulled its blockbuster painkiller Vioxx from shelves in September, is about to become the target of hundreds of plaintiffs’ lawyers, the New York Times reported on Friday.

The report said that the attorneys, representing people who claim injury or death because of the use of Vioxx, plan to meet next week to lay the foundations for a nationwide blitz against Merck.

Merck has been buffeted since the company pulled Vioxx after it was shown to increase the risk of heart attack and strokes.

The Times said lawyers expect the discussions to begin informally on Tuesday in Pasadena, Calif., in the hallways of a conference on Vioxx litigation that will also be open to defense lawyers.

On Thursday, at a meeting in Las Vegas, only lawyers of those who are suing Merck, or plan to, expect to discuss specific strategies, the report added.

Reserve, Louisiana-based Daniel E. Becnel Jr. told the newspaper that the Vioxx case “needs to be managed by the premier lawyers in the country.”

The specter of litigation against Merck has increased since the recall was issued in late September.

On Thursday, Swiss scientists writing in a report for British medical journal The Lancet said that the company should have pulled Vioxx four years ago because of data showing an elevated risk of a cardiovascular event.

But Merck disputed the idea it knew of the COX-2 inhibitor’s problems that far in advance. Vioxx has been taken by an estimated 20 million Americans since its launch in 1999.

Provided by ArmMed Media
Revision date: July 3, 2011
Last revised: by Dave R. Roger, M.D.

Lawyers to meet next week on Merck’s Vioxx - NYT Bookmark this! Lawyers to meet next week on Merck’s Vioxx - NYT

RELATED STORIES:


 Comments [ + Post Your Own

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]




We are pleased to let readers post comments about an article. Please increase the credibility of your post by including your full name and email.

All comments are reviewed by our editors before they are posted on the site. Just keep it clean, kids.

Name:

Email:

Location:

URL:

Remember my personal information

Notify me of follow-up comments?

Please enter the word you see in the image below:


   [advanced search]   
What health info have you recently searched for online?
Disease or condition
Exercise or fitness
Diet, nutrition or vitamins
None of the above


Get free support - Headache Causes, Symptoms, Diagnosis, and Treatment on HeadacheCare.net


Health Centers







Diabetes

















Health news
  


Health Encyclopedia

Diseases & Conditions

Drugs & Medications

Health Tools

Health Tools



   Health newsletter

  





   Medical Links



   RSS/XML News Feed



   Feedback


Add to Yahoo RSS News Feed



Google Reader




Syndicate


This website is accredited by Health On the Net Foundation. Click to verify. We comply with the HONcode standard for trustworthy health information:
Verify here.




Human Rights in Patient Care - Practitioner Guide

hit counter